Logo image of BOAC

BLUESCAPE OPPORTUNITIES AC-A (BOAC) Stock Fundamental Analysis

NYSE:BOAC - New York Stock Exchange, Inc. - KYG1195N1051 - Common Stock - Currency: USD

10.03  0 (0%)

Fundamental Rating

1

Taking everything into account, BOAC scores 1 out of 10 in our fundamental rating. BOAC was compared to 0 industry peers in the Unkown industry. While BOAC seems to be doing ok healthwise, there are quite some concerns on its profitability. BOAC is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

BOAC had positive earnings in the past year.
BOAC had a negative operating cash flow in the past year.
BOAC Yearly Net Income VS EBIT VS OCF VS FCFBOAC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 0 20M -20M 40M -40M

1.2 Ratios

Industry RankSector Rank
ROA 11.64%
ROE 17.14%
ROIC N/A
ROA(3y)14.97%
ROA(5y)N/A
ROE(3y)23.72%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BOAC Yearly ROA, ROE, ROICBOAC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 0 20 40 60

1.3 Margins

BOAC does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BOAC Yearly Profit, Operating, Gross MarginsBOAC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022

More info and screens

5

2. Health

2.1 Basic Checks

Compared to 1 year ago, BOAC has less shares outstanding
BOAC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BOAC Yearly Shares OutstandingBOAC Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 20M 40M 60M
BOAC Yearly Total Debt VS Total AssetsBOAC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 200M 400M 600M

2.2 Solvency

BOAC has an Altman-Z score of 5.16. This indicates that BOAC is financially healthy and has little risk of bankruptcy at the moment.
BOAC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 5.16
ROIC/WACCN/A
WACCN/A
BOAC Yearly LT Debt VS Equity VS FCFBOAC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 0 100M 200M 300M 400M 500M

2.3 Liquidity

BOAC has a Current Ratio of 0.94. This is a bad value and indicates that BOAC is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.94 indicates that BOAC may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.94
Quick Ratio 0.94
BOAC Yearly Current Assets VS Current LiabilitesBOAC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 500K 1M 1.5M 2M 2.5M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for BOAC have decreased strongly by -66.31% in the last year.
EPS 1Y (TTM)-66.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%130.86%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 45.59 indicates a quite expensive valuation of BOAC.
Compared to an average S&P500 Price/Earnings ratio of 26.54, BOAC is valued quite expensively.
Industry RankSector Rank
PE 45.59
Fwd PE N/A
BOAC Price Earnings VS Forward Price EarningsBOAC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BOAC Per share dataBOAC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BOAC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BLUESCAPE OPPORTUNITIES AC-A

NYSE:BOAC (10/30/2023, 8:04:01 PM)

10.03

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)08-14 2023-08-14
Earnings (Next)11-13 2023-11-13
Inst Owners2.89%
Inst Owner Change0%
Ins Owners5.74%
Ins Owner Change0%
Market Cap226.58M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 45.59
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.45
P/tB 4.45
EV/EBITDA N/A
EPS(TTM)0.22
EY2.19%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0
BVpS2.25
TBVpS2.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 11.64%
ROE 17.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)14.97%
ROA(5y)N/A
ROE(3y)23.72%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.94
Quick Ratio 0.94
Altman-Z 5.16
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-66.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%130.86%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y23.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y23.93%
OCF growth 3YN/A
OCF growth 5YN/A